SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060339
Filing Date
2023-11-07
Accepted
2023-11-07 16:40:36
Documents
95
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rckt-20230930.htm   iXBRL 10-Q 2644388
2 EX-31.1 rckt-ex31_1.htm EX-31.1 17966
3 EX-31.2 rckt-ex31_2.htm EX-31.2 18226
4 EX-32.1 rckt-ex32_1.htm EX-32.1 14280
5 GRAPHIC img172941496_0.jpg GRAPHIC 169971
6 GRAPHIC img172941496_1.jpg GRAPHIC 46831
  Complete submission text file 0000950170-23-060339.txt   11838617

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rckt-20230930.xsd EX-101.SCH 69735
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rckt-20230930_lab.xml EX-101.LAB 495515
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rckt-20230930_cal.xml EX-101.CAL 59264
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rckt-20230930_pre.xml EX-101.PRE 461662
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rckt-20230930_def.xml EX-101.DEF 311883
89 EXTRACTED XBRL INSTANCE DOCUMENT rckt-20230930_htm.xml XML 2381903
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 231384580
SIC: 2834 Pharmaceutical Preparations